Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Expand
titleto.xpt (tobacco identifiers, design paramters)

(This is a copy from the SDTM Example. Cigarette Design Parameters, will need to revise if this changes on the Product Description team)

Rows 1-4:Show the records for the product identifiers for the tobacco product identified in SPTOBID. These records are categorized as product identifiers by TOCAT = PRODUCT IDENTIFIERS.
Rows 5-10:Show the records for the product descriptors for the tobacco product identified in SPTOBID. These records are categorized as product identifiers by TOCAT = PRODUCT DESCRIPTOR.


to.xpt

Row

STUDYID

DOMAIN

SPTOBID

TOSEQ

TOTESTCD

TOTEST

TOCAT

TOORRES

TOORRESU

TOSTRESC

TOSTRESN

TOSTRESU

1TOB07TOCIG01a

1

TBPRDCATTobacco Product CategoryPRODUCT IDENTIFIERCigarette
Cigarette

2TOB07TOCIG01a2TBPRSCATTobacco Product SubcategoryPRODUCT IDENTIFIERFiltered, Combusted
Filtered, Combusted

3TOB07TOCIG01a3MANUFManufacturerPRODUCT IDENTIFIERJoes Cigs USA
Joes Cigs USA

4TOB07TOCIG01a4TRADENAMTrade NamePRODUCT IDENTIFIERTreetop Menthol King Size
Treetop Menthol King Size

5TOB07TOCIG01a5PACKTYPPackage TypePRODUCT DESCRIPTORHARD PACK
HARD PACK

6TOB07TOCIG01a6PRDQUANProduct QuantityPRODUCT DESCRIPTOR20CIGARETTE2020CIGARETTE
7TOB07TOCIG01a7LENGTHLengthPRODUCT DESCRIPTOR86.0mm86.086.0mm
8TOB07TOCIG01a8CIRCUMFCircumferencePRODUCT DESCRIPTOR26.0mm26.026.0mm
9TOB07TOCIG01a9VENTLTNVentilationPRODUCT DESCRIPTOR10.0%10.010.0%
10TOB07TOCIG01a10CHARFLAVCharacterizing FlavorPRODUCT DESCRIPTORMENTHOL
MENTHOL

Expand
titletx.xpt (trial sets)
  • During CT definition/reviews will decide appropriate TXPARM and TXVAL; Treatment duration may be controlled;  For now, we just include good example values based on our experience
  • Assumption: The Trial Sets (TX) domain provides the list of distinct sets of subjects having different experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations as specified in the trial design.
  • Where is TK6 cell type?  is this test system (see below)
    • needs to be allowed to vary down to the well level / result level

A1:


A2:                                   

S9
RowSTUDYIDASSAYIDDOMAINSETCD
SET (what sponsor calls it, more meaningful label for Tables)
TXSEQTXPARMCDTXPARMTXVAL

123MNvitTX

A1

(table 1, row 1, ST exposure with S9)

ST+S9S9C01METACTMetabolic Activation  (this is the type of activation used)+S9

123MNvitTXA1ST+S9S9C02METACTFLY/N presence of metabolic activation (this indicates that metabolic activation was used)Y







TDURMINTreatment Duration Min (ask Jon the terminology used)







TDURTRGTreatment Target







TDURMAXTreatment Duration Max







RECVMINRecovery Duration Min







RECVTRGRecovery Duration Target







RECVMAXRecovery Duration Max







RECVURecovery Duration Unit







INCBTEMPIncubation Temperature







INCBTMPUIncubation Temperature Unit







MEDIAComposition of Media







HUMIDAtmospheric Humidity







ATMCO2Atmospheric CO2







...


123MNvitTXA1ST+S9S9C03TRTDRTRGTreatment Duration target. (how do we show 3-6 hour range?  start/end, target and tolerance?, one text field not-analyzable)3

123MNvitTXA1ST+S9S9C04TRTDRTOLTreatment Duration Tolerance

123MNvitTXA1ST+S9S9C05TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)H

123MNvitTXA1ST+S9S9C06INTRVN

name of the intervention article

(Tobacco ProdA, Bleomycin or Cyclophosphamid A)

Tobacco ProdA

123MNvitTXA1ST+S9S9C07ITVTYPE

type of intervention article

choices of values:  product; negative control; positive control

Product

123MNvitTXA1ST+S9S9C08ITVCONCConcentration of intervention article0

123MNvitTXA1ST+S9S9C09ITVCONCUConcentration Unitug/ml

123MNvitTXA1ST+S9C010SPDEVIDSponsor defined device identifierPUFFMASTER3K

123MNvitTXA1ST+S9S9C011DUREFIDSmoke RegimenMedium Intensity Regimen

123MNvitTX

A2

(table 1, row 2, ST exposure with S9 at concentration 1250)

ST+S9-12501METACTMetabolic Activation  (should there be two parms? Presence, type)?+S9

123MNvitTXA2
2METACTFLY/N presence of metabolic activation (this indicates that metabolic activation was used)Y

123MNvitTXA2
3TRTDRTRGTreatment Duration target. (how do we show 3-6 hour range?  start/end, target and tolerance?, one text field not-analyzable)3

123MNvitTXA2
4TRTDRTOLTreatment Duration Tolerance

123MNvitTXA2
5TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)H

123MNvitTXA2
6INTRVNname of the intervention articleTobacco ProdA

123MNvitTXA2
7ITVTYPEtype of intervention articleProduct

123MNvitTXA2
8ITVCONCConcentration of i a 1250

123MNvitTXA2
9ITVCONCUConcentration Unitug/ml

123MNvitTXA2
10SPDEVIDSponsor defined device identifierPUFFMASTER2023

123MNvitTXA2
11DUREFIDSmoke RegimenHigh Intensity Regimen
...








...